Psychoanaleptics and central nervous system drugs

This tender for psychoanaleptics and central nervous system drugs is well-structured with clear requirements and transparent evaluation criteria, facilitating fair competition. Minor improvements could include explicit contract duration and NUTS code provision for enhanced completeness.

The tender generally complies with legal requirements, including clearly defined procedure type, reasonable deadlines, and adherence to EU sanctions. The CPV code is specific and appropriate. However, the NUTS code is missing, which is a minor omission for full geographical classification.

The tender description is clear, and requirements are well-documented and understandable, covering exclusion, eligibility, technical, financial, and submission aspects. Crucially, evaluation criteria are explicitly defined in Document 3 as solely based on the lowest total cost, contradicting the automated check's flag.

Basic information, deadlines, estimated value, and detailed requirements are provided. While documents are attached, the explicit contract duration is not stated in the main overview, only the bid validity. The NUTS code is also missing.

The tender demonstrates high fairness with full document access, disclosed estimated value, reasonable preparation time, and objective, transparent evaluation criteria (lowest price). E-procurement is enabled, and requirements appear generic, showing no signs of being tailored to a specific company.

Electronic submission and e-procurement are supported, enhancing practicality. However, the contract start date is not explicitly known from the provided information, and the contract duration is not clearly specified beyond the bid validity period. Financing details are limited to the estimated value.

Key fields are mostly populated, and there are no reported disputes or suspensions. Dates are logical and consistent. The automated check's flag regarding missing evaluation criteria is incorrect, as Document 3 clearly defines them.

The tender does not explicitly include green procurement, social aspects, or innovation focus. It is also not indicated as EU funded. This is common for standard medical supply procurements but means no points are gained in this category.